Background. Erythrocebus patas (patas) monkeys were used to model antiretroviral (ARV) drug in human immunode-ficiency virus type 1–infected pregnant women. Methods. Pregnant patas dams were given human-equivalent doses of ARVs daily during 50 % of gestation. Mesenchymal cells, cultured from bone marrow of patas offspring obtained at birth and at 1 and 3 years of age, were examined for geno-toxicity, including centrosomal amplification, micronuclei, and micronuclei containing whole chromosomes. Results. Compared with controls, statistically significant increases (P <.05) in centrosomal amplification, micronuclei, and micronuclei containing whole chromosomes were found in mesenchymal cells from most groups of offspring at the 3 time point...
Background/Objectives: Nucleoside reverse transcriptase inhibitors (NRTIs) as part of highly active...
(See the editorial commentary by Bulterys et al., on pages 2149–53.) Because milk-borne transmission...
The Surveillance Monitoring for ART Toxicities (SMARTT) cohort of the Pediatric HIV/AIDS Cohort Stud...
(See the major article by André-Schmutz et al on pages 235–43) Background. Erythrocebus patas (patas...
Antiretroviral nucleoside reverse transcriptase inhibitors (NRTIs), given tohuman immunodeficiencyvi...
The use of raltegravir in treating HIV/AIDS has been proposed due to its effectiveness in suppressin...
Zidovudine-based antiretroviral therapies (ART) for treatment of HIV-infected pregnant women have ma...
International audienceBACKGROUND: The genotoxicity of zidovudine has been established in experimenta...
Background: Zidovudine experimental genotoxicity has been established. Objective of the study was t...
Prevention of mother-to-child transmission (MTCT) of HIV remains a major objective where antenatal c...
Abstract Background Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an important catego...
To model human immunodeficiency virus (HIV) perinatal transmission, we studied infection of simian-h...
HIV kills more than 2 million people worldwide, annually. Progressive HIV disease is marked by the l...
Since the worldwide introduction of antiretroviral therapy (ART) in human immunodeficiency virus typ...
Antiretroviral therapy (ART) in pregnancy has dramatically reduced HIV vertical transmission rates. ...
Background/Objectives: Nucleoside reverse transcriptase inhibitors (NRTIs) as part of highly active...
(See the editorial commentary by Bulterys et al., on pages 2149–53.) Because milk-borne transmission...
The Surveillance Monitoring for ART Toxicities (SMARTT) cohort of the Pediatric HIV/AIDS Cohort Stud...
(See the major article by André-Schmutz et al on pages 235–43) Background. Erythrocebus patas (patas...
Antiretroviral nucleoside reverse transcriptase inhibitors (NRTIs), given tohuman immunodeficiencyvi...
The use of raltegravir in treating HIV/AIDS has been proposed due to its effectiveness in suppressin...
Zidovudine-based antiretroviral therapies (ART) for treatment of HIV-infected pregnant women have ma...
International audienceBACKGROUND: The genotoxicity of zidovudine has been established in experimenta...
Background: Zidovudine experimental genotoxicity has been established. Objective of the study was t...
Prevention of mother-to-child transmission (MTCT) of HIV remains a major objective where antenatal c...
Abstract Background Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an important catego...
To model human immunodeficiency virus (HIV) perinatal transmission, we studied infection of simian-h...
HIV kills more than 2 million people worldwide, annually. Progressive HIV disease is marked by the l...
Since the worldwide introduction of antiretroviral therapy (ART) in human immunodeficiency virus typ...
Antiretroviral therapy (ART) in pregnancy has dramatically reduced HIV vertical transmission rates. ...
Background/Objectives: Nucleoside reverse transcriptase inhibitors (NRTIs) as part of highly active...
(See the editorial commentary by Bulterys et al., on pages 2149–53.) Because milk-borne transmission...
The Surveillance Monitoring for ART Toxicities (SMARTT) cohort of the Pediatric HIV/AIDS Cohort Stud...